Lopinavir; Ritonavir Patent Expiration
Lopinavir; Ritonavir is used for treating HIV-1 infection in combination with other antiretroviral agents. It was first introduced by Abbvie Inc
Lopinavir; Ritonavir Patents
Given below is the list of patents protecting Lopinavir; Ritonavir, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Kaletra |
US8025899 (Pediatric) | Solid pharmaceutical dosage form | Jun 14, 2028 | Abbvie |
| Kaletra |
US8377952 (Pediatric) | Solid pharmaceutical dosage formulation | Apr 22, 2028 | Abbvie |
| Kaletra | US8025899 | Solid pharmaceutical dosage form | Dec 14, 2027 | Abbvie |
| Kaletra | US8377952 | Solid pharmaceutical dosage formulation | Oct 22, 2027 | Abbvie |
| Kaletra |
US8470347 (Pediatric) | Self-emulsifying active substance formulation and use of this formulation | Mar 17, 2027 | Abbvie |
| Kaletra | US8470347 | Self-emulsifying active substance formulation and use of this formulation | Sep 17, 2026 | Abbvie |
| Kaletra |
US8309613 (Pediatric) | Solid pharmaceutical dosage form |
Jun 24, 2025
(Expired) | Abbvie |
| Kaletra |
US8268349 (Pediatric) | Solid pharmaceutical dosage form |
Feb 25, 2025
(Expired) | Abbvie |
| Kaletra |
US8399015 (Pediatric) | Solid pharmaceutical dosage form |
Feb 25, 2025
(Expired) | Abbvie |
| Kaletra |
US8691878 (Pediatric) | Solid pharmaceutical dosage form |
Feb 25, 2025
(Expired) | Abbvie |
| Kaletra | US8309613 | Solid pharmaceutical dosage form |
Dec 24, 2024
(Expired) | Abbvie |
| Kaletra | US8268349 | Solid pharmaceutical dosage form |
Aug 25, 2024
(Expired) | Abbvie |
| Kaletra | US8399015 | Solid pharmaceutical dosage form |
Aug 25, 2024
(Expired) | Abbvie |
| Kaletra | US8691878 | Solid pharmaceutical dosage form |
Aug 25, 2024
(Expired) | Abbvie |
| Kaletra |
US6911214 (Pediatric) | Flavoring systems for pharmaceutical compositions and methods of making such compositions |
May 28, 2022
(Expired) | Abbvie |
| Kaletra | US6911214 | Flavoring systems for pharmaceutical compositions and methods of making such compositions |
Nov 28, 2021
(Expired) | Abbvie |
| Kaletra | US8501219 | Flavoring systems for pharmaceutical compositions and methods of making such compositions |
Nov 28, 2021
(Expired) | Abbvie |
| Kaletra |
US7364752 (Pediatric) | Solid dispersion pharamaceutical formulations |
May 10, 2021
(Expired) | Abbvie |
| Kaletra |
US7141593 (Pediatric) | Pharmaceutical formulations |
Nov 22, 2020
(Expired) | Abbvie |
| Kaletra |
US7432294 (Pediatric) | Pharmaceutical formulations |
Nov 22, 2020
(Expired) | Abbvie |
| Kaletra | US7364752 | Solid dispersion pharamaceutical formulations |
Nov 10, 2020
(Expired) | Abbvie |
| Kaletra | US7141593 | Pharmaceutical formulations |
May 22, 2020
(Expired) | Abbvie |
| Kaletra | US7432294 | Pharmaceutical formulations |
May 22, 2020
(Expired) | Abbvie |
| Kaletra |
US7148359 (Pediatric) | Polymorph of a pharmaceutical |
Jan 19, 2020
(Expired) | Abbvie |
| Kaletra | US7148359 | Polymorph of a pharmaceutical |
Jul 19, 2019
(Expired) | Abbvie |
| Kaletra |
US6232333 (Pediatric) | Pharmaceutical composition |
May 07, 2018
(Expired) | Abbvie |
| Kaletra |
US6458818 (Pediatric) | Pharmaceutical composition |
May 07, 2018
(Expired) | Abbvie |
| Kaletra |
US6521651 (Pediatric) | Pharmaceutical composition |
May 07, 2018
(Expired) | Abbvie |
| Kaletra | US6232333 | Pharmaceutical composition |
Nov 07, 2017
(Expired) | Abbvie |
| Kaletra | US6458818 | Pharmaceutical composition |
Nov 07, 2017
(Expired) | Abbvie |
| Kaletra | US6521651 | Pharmaceutical composition |
Nov 07, 2017
(Expired) | Abbvie |
| Kaletra |
US6037157 (Pediatric) | Method for improving pharmacokinetics |
Dec 26, 2016
(Expired) | Abbvie |
| Kaletra |
US6703403 (Pediatric) | Method for improving pharmacokinetics |
Dec 26, 2016
(Expired) | Abbvie |
| Kaletra |
US6284767 (Pediatric) | Retroviral protease inhibiting compounds |
Aug 15, 2016
(Expired) | Abbvie |
| Kaletra | US6037157 | Method for improving pharmacokinetics |
Jun 26, 2016
(Expired) | Abbvie |
| Kaletra | US6703403 | Method for improving pharmacokinetics |
Jun 26, 2016
(Expired) | Abbvie |
| Kaletra |
US5914332 (Pediatric) | Retroviral protease inhibiting compounds |
Jun 13, 2016
(Expired) | Abbvie |
| Kaletra | US6284767 | Retroviral protease inhibiting compounds |
Feb 15, 2016
(Expired) | Abbvie |
| Kaletra | US5914332 | Retroviral protease inhibiting compounds |
Dec 13, 2015
(Expired) | Abbvie |
| Kaletra |
US5648497 (Pediatric) | Retroviral protease inhibiting compounds |
Jan 15, 2015
(Expired) | Abbvie |
| Kaletra |
US5484801 (Pediatric) | Pharmaceutical composition for inhibiting HIV protease |
Jul 28, 2014
(Expired) | Abbvie |
| Kaletra | US5648497 | Retroviral protease inhibiting compounds |
Jul 15, 2014
(Expired) | Abbvie |
| Kaletra |
US5886036 (Pediatric) | Retroviral protease inhibiting compounds |
May 19, 2014
(Expired) | Abbvie |
| Kaletra |
US5948436 (Pediatric) | Pharmaceutical composition |
Mar 13, 2014
(Expired) | Abbvie |
| Kaletra |
US5541206 (Pediatric) | Retroviral protease inhibiting compounds |
Jan 30, 2014
(Expired) | Abbvie |
| Kaletra | US5484801 | Pharmaceutical composition for inhibiting HIV protease |
Jan 28, 2014
(Expired) | Abbvie |
| Kaletra | US5886036 | Retroviral protease inhibiting compounds |
Nov 19, 2013
(Expired) | Abbvie |
| Kaletra | US5948436 | Pharmaceutical composition |
Sep 13, 2013
(Expired) | Abbvie |
| Kaletra | US5541206 | Retroviral protease inhibiting compounds |
Jul 30, 2013
(Expired) | Abbvie |
Lopinavir; Ritonavir's Family Patents
